+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

ASPO Dustin Micah Harper Recurrent Respiratory Papillomatosis (RRP) Research Grant

American Society of Pediatric Otolaryngology (ASPO)

The purpose of this award is to support basic, translational, or clinical research projects in recurrent respiratory papillomatosis (RRP). Clinical or translational research studies are strongly encouraged and should be specifically related to the prevention, diagnosis, treatment, outcomes, or pathophysiology of RRP disease.

TERMS

1. Amount: $10,000

2. Period: 12 months, non-renewable; maximum of one year no-cost extension allowable with permission of ASPO Research Committee Chair.

3. Use of Funds: A detailed budget and budget justification constitute part of the application and will be evaluated as part of the review process. Funding may not be used to support the Principal Investigator’s salary during the period of the award. Allowable expenses include consultant fees (e.g., statistician); salary support for research assistants or other technical personnel; computer software or hardware; purchase and maintenance of experimental animals; laboratory supplies and services; and expenses related to publication of results directly related to the supported project, exclusive of reprint costs. Equipment and supplies purchased with this Award become the property of the recipient institution. The ASPO prefers not to pay institutional (indirect) costs for this very modest award. If university policy stipulates that a portion of this very modest award must go toward institutional indirect costs, no more than ten percent (10%) of the total direct costs may be applied for indirect costs. The Total Costs (direct + indirect) may not exceed $10,000.

4. Review: Applications will be reviewed and scored by members of the Centralized Otolaryngology Research Efforts (CORE) Study Section, composed of ASPO members designated for the Study Section, and members of the AAO-HNSF CORE Study Section Subcommittee. Based on these reviews, the ASPO Research Committee makes recommendations for funding which are presented to the ASPO Board at its COSM meeting. Final funding decisions are made by the ASPO Board.

5. Notification: Letters of notification will be sent by June of the award year. Please do not call the AAOHNSF office prior to that time to inquire about results. Questions may be directed to the ASPO Research Committee Chair (see ASPO website at www.aspo.us for contact information)

6. Start Date: The recipient of the ASPO Dustin Micah Harper RRP Research Grant will be announced publicly at the closest AAO-HNS Foundation Annual Meeting immediately following the award. Verification of human subjects approval and/or animal use approval, as applicable, as well as verification of tax exempt status must be received prior to release of funds. The awards may be activated as early as July 1 of the year of award, but no later than January 1 of the following year. ASPO reserves the right to revoke an award if relevant approvals have not been obtained within 6 months of notification of a successful application.

AI Based Application Success Predictor

1. Strong Pediatric Relevance — Ear / Airway / Head-Neck in Children

The research question should explicitly involve pediatric patients (newborns, infants, children, adolescents).

Conditions typical to pediatric ENT: congenital anomalies (microtia, atresia, choanal atresia), pediatric airway/ airway reconstruction, hearing/implantation in children, pediatric tumors, congenital ear bone issues, pediatric sinus/larynx disorders — stand out.

Studies that involve age-specific physiology / growth / developmental outcomes or address long-term pediatric-specific issues (growth, hearing development, speech) are especially compelling.

Predictor: The more directly the project addresses pediatric ENT needs (not adult ENT), the higher the relevance.

2. Clinical or Translational Impact — Real Benefit for Child Patients

Because pediatric ENT often deals with life-changing conditions (hearing, airway, development), proposals with clear translational or clinical benefit are strong:

Innovations in surgical techniques or implants tailored to children (e.g. smaller implants, growth-accommodating implants)

Improvements in patient outcomes: hearing, speech, airway patency, developmental milestones, quality-of-life

Long-term follow-up studies on growth, development, function — particularly important in children

Interventions that reduce morbidity or complications unique to pediatric populations

Predictor: Demonstrable potential to improve care for children — not just academic interest.

3. Feasible Design & Well-Scoped Aims (Given Pediatric Populations)

Working with children adds complexity (recruitment, consent, growth, follow-up). Therefore:

Proposals with realistic, focused aims — e.g., pilot or feasibility studies, small cohorts, clear endpoints — are preferred.

Realistic timeline: e.g. 12–24 months with defined follow-up, not overly long or overly broad scope initially.

Appropriate ethical, regulatory planning (pediatric IRB, consent/assent, minimal-risk design, safeguards)

Predictor: Feasibility and realistic scope — showing awareness of pediatric-specific constraints — improves chances.

4. Institutional & Multidisciplinary Support + Pediatric-ENT Clinical Volume

Because many pediatric ENT conditions are rare or specialized:

Access to a high-volume pediatric ENT center (for recruitment, surgeries, follow-up) helps.

Institutional support: pediatric anesthesiology, audiology, speech-language pathology, developmental pediatrics, radiology, etc. — enhances comprehensiveness.

Team-based, collaborative approach (ENT surgeon + audiologist + developmental specialist + perhaps basic-science researcher) increases robustness.

Predictor: Strong institutional infrastructure and multidisciplinary collaboration strengthens proposal credibility.

5. Investigator Background / Training & Commitment to Pediatric ENT Research

Whether applicant is a fellow, junior faculty, or attending surgeon:

Demonstrated interest or prior work in pediatric ENT (clinical or research) raises confidence.

For early-career applicants: mentorship by experienced pediatric ENT with proven track record, protected research time, access to patients/resources.

For senior applicants: proven surgical/clinical volume, prior pediatric ENT outcomes, or prior research in pediatric ENT increases reputational trust.

Predictor: Applicant’s pediatric ENT credentials + mentorship and institutional commitment enhance likelihood of success.

6. Ethical, Patient-Centered Design, Long-Term Follow-up & Planning

Children grow/change — follow-up over time, developmental assessments, long-term safety/outcome monitoring — thus proposals emphasizing:

Longitudinal follow-up (hearing, speech, growth)

Comprehensive patient-centered outcomes (quality of life, developmental milestones)

Safety, ethical conduct, family-centered care, consent/assent procedures

Predictor: Thoughtful, child-centered design showing concern for long-term welfare is very favorable.

7. Realistic Budget & Resource Request — No Overreach

Because pediatric ENT research (especially surgical / clinical) can be expensive — but funding may be limited — success tends to follow applications that:

Request budgets justified and proportional to aims (no overspending)

Focus on deliverables (data collection, follow-up, imaging, audiology, etc.) rather than big capital investments — especially if seed-funding

Predictor: Lean, justified budgets aligned with project scope are more competitive.

8. Plan for Dissemination, Contribution to Standards, and Future Research or Clinical Practice Impact

Strong applications often include:

Publication plans, presentations at pediatric-ENT or general ENT conferences

Plans to integrate findings into clinical protocols, guidelines, or standard-of-care practice (if relevant)

Future grant or study expansion (multi-center, long-term follow-up, broader cohorts)

Predictor: Vision for real-world impact beyond just the study increases value.

🎯 What This Means If You Plan to Submit to ASPO

If you’re preparing an ASPO-linked grant or research proposal, aim to:

Center the project on children — pediatric ENT/airway/ear/neck disease or developmental outcomes.

Propose feasible, realistic, focused aims, with careful awareness of the challenges of pediatric research (consent, follow-up, growth, variability).

Ensure access to a high-volume pediatric ENT clinical center and necessary multidisciplinary support (audiology, anesthesiology, pediatrics, imaging, etc.).

For early-career: secure mentorship and institutional commitment, with protected research time.

Build a patient-centered design with longitudinal follow-up, developmental/functional outcomes, and ethical safeguards.

Craft a lean, justified budget, scaled to aims and grant size.

Include a dissemination and long-term impact plan — how results will inform clinical practice or lead to expanded research.

Specialties

Clinical Trials

Otolaryngology

Eligibility Requirements

Candidates for this award should reside in the U.S. or Canada, be medical students, residents, fellows, private practitioners, PhDs or faculty members. Junior faculty who graduated within 10 years of completing their training will be preferred for this application. Previous ASPO or AAO-HNS Foundation research grant recipients are eligible to compete for this grant. Candidates who have applied for support of the same research from other funding sources, and who are notified of an award from both another agency and from ASPO must choose only one of the awards.

Eligible Countries:

Canada

United States

Sponsor Details

Sponsor Institute/Organizations: American Society of Pediatric Otolaryngology (ASPO)

Sponsor Type: Corporate/Non-Profit

Address: 1650 Diagonal Rd Alexandria VA 22314 1-703-836-4444

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity